Target intelligence / Profile preview

Alanine dehydrogenase (ALD)

Target
ALD
Molecular classification
Enzyme, Oxidoreductase, Amino acid oxidoreductase
01

Overview

Alanine dehydrogenase (ALD) is an enzyme that catalyzes the reversible oxidative deamination of L-alanine to pyruvate, with concurrent reduction of NAD+ to NADH. It is a homo-hexameric enzyme, widely found in bacteria, and plays a critical role in microbial carbon and nitrogen metabolism by enabling the interconversion of alanine and pyruvate for energy generation and biosynthetic reactions[1][2][4][6]. It participates in key metabolic pathways—including the tricarboxylic acid (TCA) cycle, taurine and hypotaurine metabolism, and CO2 fixation[2][3][4]. In some pathogenic bacteria, alanine dehydrogenase serves as a secreted antigen and virulence factor during infection[5]. In general, it is not a major therapeutic target in current clinical drug discovery, but its role as a microbial antigen may have diagnostic applications[5]. The enzyme is not known to interact with specific approved drugs.

Other names
L-alanine dehydrogenaseAlaDHNAD+-linked alanine dehydrogenasealpha-alanine dehydrogenaseNAD+-dependent alanine dehydrogenasealanine oxidoreductaseNADH-dependent alanine dehydrogenase
02

Mechanism of action

Catalysis of NAD+-dependent reversible conversion of L-alanine and pyruvate via hydride transfer and deamination (targeted as an antigen/virulence factor in some bacterial pathogens)

03

Biological functions

Catalysis of reversible oxidative deamination of L-alanine to pyruvateCentral role in nitrogen and carbon metabolism in microorganismsParticipation in taurine and hypotaurine metabolismInvolvement in CO2 fixation (reductive carboxylate cycle)
04

Disease associations

Infection (involved as a virulence factor and antigen in pathogens, including *Mycobacterium tuberculosis* and *Mycobacterium marinum*)Other
05

Safety considerations

Limited human safety data available, safety concerns not described in therapeutic context (bacterial ALD may be immunogenic but is not a common drug target)
06

Biomarkers

Secretory/antigenic protein in *M. tuberculosis* and other pathogens (potential diagnostic marker for infection)

Beyond the preview

Go deeper on Alanine dehydrogenase (ALD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alanine dehydrogenase (ALD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call